These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36626902)

  • 1. Dual-specificity RNA aptamers enable manipulation of target-specific O-GlcNAcylation and unveil functions of O-GlcNAc on β-catenin.
    Zhu Y; Hart GW
    Cell; 2023 Jan; 186(2):428-445.e27. PubMed ID: 36626902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-catenin is O-GlcNAc glycosylated at Serine 23: implications for β-catenin's subcellular localization and transactivator function.
    Ha JR; Hao L; Venkateswaran G; Huang YH; Garcia E; Persad S
    Exp Cell Res; 2014 Feb; 321(2):153-66. PubMed ID: 24342833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41.
    Olivier-Van Stichelen S; Dehennaut V; Buzy A; Zachayus JL; Guinez C; Mir AM; El Yazidi-Belkoura I; Copin MC; Boureme D; Loyaux D; Ferrara P; Lefebvre T
    FASEB J; 2014 Aug; 28(8):3325-38. PubMed ID: 24744147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
    Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
    PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation in cancer development and immunotherapy.
    He XF; Hu X; Wen GJ; Wang Z; Lin WJ
    Cancer Lett; 2023 Jul; 566():216258. PubMed ID: 37279852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-specificity RNA aptamers: A sweet new tool for studying O-GlcNAc biology.
    Cheng SS; Woo CM
    Mol Cell; 2023 Mar; 83(5):657-659. PubMed ID: 36868188
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Xu Z; Isaji T; Fukuda T; Wang Y; Gu J
    J Biol Chem; 2019 Mar; 294(9):3117-3124. PubMed ID: 30587575
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRAGE induces β-catenin/Arm O-GlcNAcylation and negatively regulates Wnt signaling.
    Chen Y; Jin L; Xue B; Jin D; Sun F; Wen C
    Biochem Biophys Res Commun; 2017 May; 487(2):433-437. PubMed ID: 28427939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
    Harosh-Davidovich SB; Khalaila I
    Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
    J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Protein O-GlcNAcylation Using Bifunctional Small Molecules.
    Ma B; Khan KS; Xu T; Xeque Amada J; Guo Z; Huang Y; Yan Y; Lam H; Cheng AS; Ng BW
    J Am Chem Soc; 2024 Apr; 146(14):9779-9789. PubMed ID: 38561350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation.
    Mitchell CW; Galan Bartual S; Ferenbach AT; Scavenius C; van Aalten DMF
    Glycobiology; 2023 Dec; 33(12):1172-1181. PubMed ID: 37856504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations in
    Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
    J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.